2.Effects of Helicobacter pylori on expression of DNA mismatch repair genes in AGS cell line
Ji-Heng WANG ; Wen-Zhong LIU ; Yue-Hua HAN ; Jufang TONG ; Hongyin ZHU ; Enling LI ;
Chinese Journal of Digestion 2001;0(11):-
Objective To investigate the effects of Helicobacter priori (H.prlori) strains from the patient with gastric cancer on the expression of DNA mismatch repair (MMR) genes in AGS cells in vitro. Methods AGS cells were co-cultured with ten strains of H.prlori from five patients with gastric cancer and five patients with gastritis respectively.The expressions of DNA MMR genes (hMSH2 and hMLH1) in mRNA and protein levels were determined by RT-PCR and Western blot.The enteropathogenic E.coli served as a bacterial control.Results E.coli and H.priori strains from gastritis have no effects on the expression of hMSH2 and hMLH1 in both protein and mRNA levels on the whole,while all the H.prlori strains from gastric cancer reduced expression levels of hMSH2 and hMLH1.Conclusions There are different effects between H. prlori strains from gastric cancer and those from gastritis on DNA MMR in AGS cell line,indicating that infec- tion of some H.prlori strains might lead to the inhibition of DNA MMR,and that in turns increases the risk of gastric carcinogenesis during chronic H.prlori infection.
3.Pioglitazone administration combined with bone marrow mesenchymal stem cells transplantation improved the heart function of rats with myocardial infarction
Quanhua WU ; Jingying HOU ; Tianzhu GUO ; Tingting ZHONG ; Huibao LONG ; Yue XING ; Changqing ZHOU ; Shaoxin ZHENG ; Tong WANG
Chinese Journal of Tissue Engineering Research 2015;(23):3698-3704
BACKGROUND:Our previous work has demonstrated that bone marrow mesenchymal stem cels (BMSCs) transplantation can improve the heart function of rats with myocardial infarction. However, the overal efficacy is not satisfactory. OBJECTIVE: To adopt pioglitazone as a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist combined with BMSCs transplantation therapy, thereby further improving cardiac function of rats with myocardial infarction as wel as investigating the relevant mechanisms. METHODS:Twenty Sprague-Dawley rats with myocardial infarction were induced by the left anterior descending coronary artery ligation. The animals were randomized into two groups: BMSCs and BMSCs+pioglitazone. Two weeks later, al the animals received the injection of BMSCs labeled with PKH26 in PBS into the local infarct zone, and then pioglitazone (3 mg/kg/d) was given by the oral gavage for 2 weeks in the BMSCs+pioglitazone group after the cel transplantation. After 2 weeks of cel transplantation, cardiac functions were evaluated by echocardiography. The expressions of PPAR-γ, Connexin 43 and molecules in TGF-β1/SMAD signaling pathway were examined in different areas of the left ventricle from each harvested heart using immunofluorescent staining, western blot assay and qRT-PCR. RESULTS AND CONCLUSION:There were no differences in the baseline parameters of cardiac function between the two groups. At 2 weeks after cel transplantation, the left ventricular internal diameter at end-diastole, left ventricular internal diameter at end-systole and left ventricular ejection fraction were significantly improved in the BMSCs+ pioglitazone group; the expressions of PPAR-γ and Connexin 43 were distinctly increased in different zones of the left ventricle; the levels of TGF-β1, SMAD2 and SMAD3 were obviously attenuated in the infarct zone and border zone. The above-mentioned findings suggest that pioglitazone, a PPAR-γ agonist, can enhance BMSCs potential in improvingthe heart function after myocardial infarction, and PPAR-γ may elevate the expression of Connexin 43via the blockade of the TGF-β1/SMAD signaling pathway in the procedure.
4.Comparison of the therapeutic effect on skeletal fluorosis and impact on urine fluoride value among fire needle therapy, electroacupuncture and calcium carbonate D3.
Tong WANG ; Xu-Guang YANG ; Zhong-Chao WU ; Jin-Cao ZHOU ; Zhong-Jie CHEN ; Jing HU ; Yue JIAO ; Xiao-Guang ZHAO
Chinese Acupuncture & Moxibustion 2014;34(3):213-217
OBJECTIVETo observe the impacts on skeletal fluorosis pain, joint motor dysfunction and urine fluoride excretion in the treatment with fire needle therapy, electroacupuncture and calcium carbonate D3.
METHODSThe randomized controlled trial was adopted. Ninety-five patients were randomized into a fire needle group (31 cases), an electroacupuncture group (33 cases) and a calcium carbonate D3 group (31 cases). In the fire needle group and the electroacupuncture group, Ashi points, Dazhui (GV 14), Geshu (BL 17), Quchi (LI 11), Hegu (LI 4), Xuehai (SP 10) points were selected and stimulated with fire needle and electroacupuncture separately, three times a week. In the calcium carbonate D3 group, calcium carbonate D3 tablets was prescribed for oral administration, 600 mg each time, twice a day. The duration of treatment was 2 months in the electroacupuncture group and calcium carbonate D3 group and 1 month in the fire needle group. VAS score, the range of motion (ROM) and urine fluoride value were compared before and after treatment in the patients of the three groups.
RESULTSAfter treatment, VAS value and ROM were improved significantly in the patients of the three groups (all P < 0.05), the difference was not significant in comparison of the three groups (all P > 0.05). After treatment, the urine fluoride value was increased significantly in the fire needle group [(7.89 +/- 3.61) mg/L vs (9.81 +/- 4.17) mg/L, P < 0.01] and was increased in the electroacupuncture group [(7.53 +/- 3.46) mg/L vs (8.97 +/- 4.21) mg/L, P < 0.05]. The difference was not significant in comparison before and after treatment in the calcium carbonate D3 group (P > 0.05).
CONCLUSIONThe fire needle therapy, electroacupuncture and calcium carbonate D3 all have the clinical value in the prevention and treatment of skeletal fluorosis and the difference in the therapeutic effect has not been discovered among them yet at present. But it has been found that the fire needle therapy and electroacupuncture display the active significance in the promotion of urine fluoride excretion.
Adult ; Aged ; Bone Diseases ; drug therapy ; therapy ; urine ; Calcium Carbonate ; administration & dosage ; Electroacupuncture ; instrumentation ; Female ; Fluorides ; urine ; Humans ; Male ; Middle Aged ; Needles ; Treatment Outcome
5.Diagnosis and treatment of intestinal stone obstruction in infants by combined use of ultrathin gastroscopy and enteroscopy.
Gui-jun JIANG ; Mei FANG ; Cheng-hong JI ; Tong SHEN ; Hui-gi FANG ; Zhong-mei ZHU ; Yue-jiao CAI ; Na-ping ZHAN
Chinese Journal of Pediatrics 2003;41(3):167-167
Female
;
Gastroscopy
;
Humans
;
Infant
;
Intestinal Obstruction
;
diagnosis
;
therapy
;
Treatment Outcome
6.Preliminary clinical observation on effect of soduim ferulate in treating diabetic nephropathy.
Feng-ming ZHENG ; Yue-zhong REN ; Tong-feng ZHAO
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(5):419-421
OBJECTIVETo investigate the effect of sodium ferulate (SF) on diabetic nephropathy (DN).
METHODSForty-eight DN patients of early stage and 54 DN patients of clinical stage were randomly divided into two groups, the conventional treatment group and the SF treatment group. Indexes, including urinary albumin excretion rate (UAER), serum endothelin (ET), blood urea nitrogen (BUN), serum creatinine (Scr) and fasting blood glucose (FBG) were observed.
RESULTSThe levels of UAER, BUN and ET were decreased in all DN patients, either early stage or clinical stage, after treated with SF for 4 weeks (P < 0.05, P < 0.01), but changed insignificantly in those treated with conventional treatment.
CONCLUSIONSF can decrease the levels of UAER and BUN in DN patients, the mechanism may relate with the decreasing of ET production and antagonizing to the binding of ET with its receptors.
Adult ; Aged ; Coumaric Acids ; therapeutic use ; Diabetes Mellitus, Type 2 ; drug therapy ; Diabetic Nephropathies ; drug therapy ; Endothelin Receptor Antagonists ; Female ; Humans ; Male ; Middle Aged ; Phytotherapy
7.Evaluation on self-treatment of patients with chronic Keshan disease in Fuyu County, Heilongjiang Province
Gai-gai, ZHANG ; Yue, LIU ; Xin-hua, YIN ; Tong, WANG ; Zhong-yu, MA ; Hong-qi, FENG ; Hong, LIU ; Jin-feng, YU ; Jun-rui, PEI ; Zi-dan, GUO
Chinese Journal of Endemiology 2008;27(5):566-569
Objective To evaluate the self-treatment effectiveness on patients with ehwnic Keshan disease.Methods Twenty patients with chronic Keshan disease were selected from individuals with Keshan disease in Fuyu County,Heilongjiang Province.They were trained three times every three months of self management including pathogenetic condition education,general guidance,drug therapy,and they also taught how to adiust the doBe of drug according to their illness.Major symptom score,heart rate(HR),ultrasoundcardiogram (UCG)index and cardiac functional grading of these patients at basehne,after 3 months and 6 months of treatment were compared.Results The 20 patients rated their main symptoms score as(15.03 ±6.77)before self- treatrnent,and significantly decreased to(7.25±4.82)and(6.70±4.90)after 3 and 6 months treatment(P<0.01); the heart rate(HR) was (76.40±12.06) beats per minute(bpm)before self-treatment,and dramatically decreased to (69.95±12.63),(67.15±9.76)bpm after 3 and 6 months treatment(P<0.01).As for UCG detecting index,left atrial diameter(Lad)aIld left ventricular end-diastolic diameter(LVEDd)Was(37.85 ±5.23)nun and(52.49± 9.38)mm separately before self-treatment,and notablely decreased to(36.77 ±5.63),(52.15 ±9.24)mm,and (35.29±5.50),(50.81±8.88)mm respectirely after 3 and 6 months of treatment(P<0.01 or<0.05);left ventricuIar ejection fractiOII(LVEF)markedly increased(P<0.05),from(55.15±15.80)%at baseline to(57.35± 12.51)%at 3 months and(60.30±13.42)%at 6 months;there were no significant differences in mitral flow E/A ratio changes before and after treatment(P>0.05);compared with prior to the treatment.cardiac function grading was significantly better aftertreatmentfor 3 months(T=36.0,P<0.05),but not after 6 months(T=17.5,P> 0.05).Conclusions The patients'serf-treatment is effective,which we recommend to uphold and widespread.
8.Evaluation of effects of self-treatment on patients with Keshan disease by echocardiography
Zhong-yu, MA ; Jing-yuan, YANG ; Tong, WANG ; Hong, LIU ; Hong-qi, FENG ; Jun-rui, PEI ; Bai-nan, XU ; Yue, LIU ; Gai-gai, ZHANG ; Zi-dan, GUO
Chinese Journal of Endemiology 2008;27(4):446-448
Objective To observe the change in cardiac shape and heart function and evaluate the effect of self-treatment on patients with Keshan disease by echocardiography. Methods To check the 31 patients with Keshan disease before the self-treatment, and follow them up in the 3rd and 6th months after self-treatment by echocardiography. The left atrium diameter(LAd), left ventricular end-diastolic diameter(LVEDd), the thickness of interventricular septum in end-diastolic(IVSTd), the thickness of LV posterior wall in end-diastolic (LVPWTd), left ventricular mass(LVM), left ventricular mass index(LVMI), left ventricular ejection fraction(LVEF) and mitral valve flow E/A ratio(E/A) were measured. Results The LAd[(35.8±5.1)ram] and LVPWTd[(9.3±1.0)mm] obviously decreased in the 3rd month after serf-treatment compared with prior self-treatment [ (37.0±5.0), (9.9± 1.2)mm](P<0.05). The LAd[(34.5±5.0)mini, IVSTd[(9.5±1.3)mm], LVEDd[(50.2±7.7)mm], LVPWTd [(8.7±1.1)mm], LVM[(196.1±87.2)g] and LVMl[(126.5±56.4)g/m2] obviously decreased in the 6th month after self-treatment compared with prior self-treatment [(37.0±5.0), (10.2±1.5), (51.3±8.1), (9.9±1.2)mm, (230.4±95.5)g, (144.0±54.6)g/m2] and in the 3rd month after self-treatment [(35.8±5.1)mm, (10.2±1.4) ram, (51.1±8.1)nun, (9.3±1.0)mm, (219.4±82.5)g, (136.8±50.0)g/m2] (P<0.05). The results of the mitral valve flow E/A ratio and LVEF in the 3nt month after self-treatment [1.0±0.5, (59.4±13.3)%] were increased compared with the prior self-treatment[0.9±0.5, (58.1±15.6)%], and the results in the 6th month after self-treat- ment[ 1.0±0.4, (60.7±13.6)%] were further inereased compared with before, but there was no signifieant differ- ence(P0.05). Conclusions Self-treatment of Keshan disease patients can improve the heart function by pre- venting left ventrieular remodeling and reversing. Echocardiography can be used as an essential technique to evalu- ate the effect of self-treatment on Keshan disease patients.
9.The circular distribution analysis on peak changes of hand-foot-mouth disease in Zhoushan City
Fei-Lin REN ; Zhen-Dong TONG ; An TANG ; Quan-Zhong GU ; Jian-Yue WANG
Journal of Preventive Medicine 2014;(7):683-686
Objective Todescribethemonthlyincidencedistributionofhand-foot-mouthdisease(HFMD)from2010to 2012inZhoushancityandtoanalyzetheseasonaltrendandthecausesofpeakchanges.Methods Circulardistribution method was used to identify the peak period of HFMD incidence.Watson -William test and Watson's U2 test were applied for comparing the peak periods respectively.Chi -square test was conducted to analyze and compare the distribution of HFMDpathogenindifferentyearsandBonferronimethodwasusedformultiplecomparisons.Results Therewasseasonal centralized tendency of HFMD incidence during 2010 to 2012 (P<0.01).The peak period occurred between 8th of May and 1st of September which showed a significant difference among three years (P<0.01).Specifically,the peak period in 2012 was earlier than that in 2010 and 201 1 (both P<0.01 ).Among the 356 reported cases with laboratory confirmed, there was significant difference between the distribution of HFMD pathogen by Chi -square test (P <0.01 ).The predominant strain was EV71 in 2010 and 2011 accounting for 58.46%and 64.62%respectively and other enteric viruses in 2012 accounting for 48.84%.The ratio of pathogens in 2012 was statistically different from that in 2010 and 201 1 respectively(bothP<0.01).Conclusion HFMDcasesoccurwithobviouspeakseason,regionalandgeographic differences.The major pathogens of EV71 in 2010 and 2011 were changed into other enteric viruses in 2012.
10.A preliminary study of markers for human hair follicle melanin stem cell.
Xing-Yu MEI ; Zhou-Wei WU ; Cheng-Zhong ZHANG ; Yue SUN ; Wei-Min SHI
Chinese Medical Journal 2019;132(9):1117-1119
Antigens, CD34
;
metabolism
;
Biomarkers
;
metabolism
;
Cell Differentiation
;
physiology
;
Hair Follicle
;
cytology
;
Humans
;
Intramolecular Oxidoreductases
;
metabolism
;
Keratinocytes
;
metabolism
;
Melanins
;
metabolism
;
Melanocytes
;
metabolism
;
PAX3 Transcription Factor
;
metabolism
;
Stem Cells
;
metabolism